August 4, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Ibere Pharmaceuticals under Item 4.01 of its Form 8-K dated August 4, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Ibere Pharmaceuticals contained therein.
Very truly yours,
/s/ Marcum LLP
Marcum LLP
Attachments
- Original document
- Permalink
Disclaimer
Ibere Pharmaceuticals published this content on 04 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2021 18:16:12 UTC.